MA Boston의 백혈병 임상 시험
백혈병 관련 연구 27개가 Boston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
피험자 모집 중3상
- MGH, Boston
HEME Home Transfusion Program
피험자 모집 중
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
피험자 모집 중관찰 연구
- Floating Hospital for Children at Tufts Medical Center, Boston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
피험자 모집 중2/3상
- Dana-Farber Cancer Institute, Boston
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
피험자 모집 중3상
- Research Site, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
피험자 모집 중2상
- Dana-Farber Cancer Institute, Boston
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
피험자 모집 중
- Dana-Farber Cancer Institute, Boston
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
피험자 모집 중2상
- Massachusetts General Hospital, Boston
CIML NK Cells With Venetoclax for AML
피험자 모집 중1상
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
피험자 모집 중1상
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
피험자 모집 중1상
- Beth Israel Deaconess Medical Center, Boston
ALL Backbone in AYAs
피험자 모집 중2상
- Dana Farber Cancer Institute, Boston
Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention
피험자 모집 중
- Mass General Brigham Cancer Institute, Boston
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
피험자 모집 중건강한 지원자 환영
- Dana-Farber Cancer Institute, Boston
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
피험자 모집 중1상
- Boston Children's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
피험자 모집 중1/2상
- Dren Investigational Site, Boston
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
피험자 모집 중관찰 연구
- Dana-Farber Cancer Institute, Boston
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
피험자 모집 중
- Massachusetts General Hospital Cancer Center, Boston
Shwachman Diamond Syndrome Registry and Study
피험자 모집 중관찰 연구
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Revumenib in Combination With 7+3 + Midostaurin in AML
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
피험자 모집 중1상
- Massachusetts General Hospital, Boston
Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
피험자 모집 중1/2상
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Mosunetuzumab for CLL MRD Clearance
피험자 모집 중1/2상
- Brigham & Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
피험자 모집 중
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital Cancer Center, Boston
다른 도시의 백혈병 시험
- Houston, TX연구 31개
- New York City, NY연구 21개
- Chicago, IL연구 19개
- Los Angeles, CA연구 17개
- Durham, NC연구 14개
- Baldwin Park, CA연구 14개
- Nashville, TN연구 13개
- Columbus, OH연구 13개
- Philadelphia, PA연구 13개
- Atlanta, GA연구 12개
- Milwaukee, WI연구 12개
- Seattle, WA연구 12개
Boston의 다른 연구
- 유방암연구 110개
- 암 (전체)연구 90개
- 비소세포폐암연구 87개
- 폐암연구 63개
- 대장직장암연구 62개
- 난소암연구 62개
- 전이성 암연구 61개
- 전립선암연구 56개
- 자궁내막암연구 51개
- 우울증연구 50개
- 심부전연구 46개
- 다발성 골수종연구 45개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.